A novel and sensitive ELISA reveals that the soluble form of IL-13R-α2 is not expressed in plasma of healthy or asthmatic subjects

Clinical and Experimental Allergy

Volumn 38, Issue 4, 2008, Pages 594-601

  O'Toole, M ^a   Legault, H ^a   Ramsey, R ^a   Wynn, T A ^b   Kasaian, M T ^a  

^a PFIZER INC   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Asthma; Biomarkers; Cytokines

Indexed keywords

ALLERGEN; BUFFER; INTERLEUKIN 13 RECEPTOR ALPHA2;

ARTICLE; ASTHMA; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; LUNG LAVAGE; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROVOCATION TEST; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SOLUBILITY;

ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; HUMANS; INTERLEUKIN-13 RECEPTOR ALPHA2 SUBUNIT; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLUBILITY;

EID: 40949144054     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2007.02921.x     Document Type: Article

References (42)

1. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev 2004 202 : 175 90.
2. Wynn TA. IL-13 effector functions. Ann Rev Immunol 2003 21 : 425 56.
3. Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998 282 : 2258 61.
4. Grunig G, Warnock M, Wakil AE et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998 282 : 2261 3.
5. Chiaramonte MG, Donaldson DD, Cheever AW, Wynn TA. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response. J Clin Invest 1999 104 : 777 85.
6. Kasaian MT, Donaldson DD, Tchistiakova L et al. Efficacy of IL-13 neutralization in a sheep model of experimental asthma. Am J Respir Cell Mol Biol 2007 36 : 368 76.
7. Corry DB, Kheradmand F. Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma. Am J Respir Med 2002 1 : 185 93.
8. Andrews R, Rosa L, Daines M, Khurana HG. Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity. J Immunol 2001 166 : 1716 22.
9. Andrews AL, Holloway JW, Puddicombe SM, Holgate ST, Davies DE. Kinetic analysis of the interleukin-13 receptor complex. J Biol Chem 2002 277 : 46073 8.
10. Madhankumar AB, Mintz A, Debinski W. Alanine-scanning mutagenesis of alpha-helix D segment of interleukin-13 reveals new functionally important residues of the cytokine. J Biol Chem 2002 277 : 43194 205.
11. Yoshikawa M, Nakajima T, Tsukidate T et al. TNF-alpha and IL-4 regulate expression of IL-13 receptor alpha2 on human fibroblasts. Biochem Biophys Res Commun 2003 312 : 1248 55.
12. Andrews AL, Nasir T, Bucchieri F, Holloway JW, Holgate ST, Davies DE. IL-13 receptor alpha 2: a regulator of IL-13 and IL-4 signal transduction in primary human fibroblasts. J Allergy Clin Immunol 2006 118 : 858 65.
13. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med 2006 12 : 99 106.
14. Fichtner-Feigl S, Fuss IJ, Young CA et al. Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol 2007 178 : 5859 70.
15. Bernard J, Treton D, Vermot-Desroches C et al. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: iL13Ralpha2 as a decoy receptor for IL13. Lab Invest 2001 81 : 1223 31.
16. Feng N, Schnyder B, Vonderschmitt DJ, Ryffel B, Lutz RA. Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor. J Recept Signal Transduct Res 1995 15 : 931 49.
17. Yasunaga S, Yuyama N, Arima K et al. The negative-feedback regulation of the IL-13 signal by the IL-13 receptor alpha2 chain in bronchial epithelial cells. Cytokine 2003 24 : 293 303.
18. Tabata Y, Chen W, Warrier MR, Gibson AM, Daines MO, Hershey GK. Allergy-driven alternative splicing of IL-13 receptor alpha2 yields distinct membrane and soluble forms. J Immunol 2006 177 : 7905 12.
19. Chiaramonte MG, Mentink-Kane M, Jacobson BA et al. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 2003 197 : 687 701.
20. Matsushita M, Yamamoto T, Nishioka K. Upregulation of interleukin-13 and its receptor in a murine model of bleomycin-induced scleroderma. Int Arch Allergy Immunol 2004 135 : 348 56.
21. Morimoto M, Morimoto M, Zhao A et al. Functional importance of regional differences in localized gene expression of receptors for IL-13 in murine gut. J Immunol 2006 176 : 491 5.
22. Wood N, Whitters MJ, Jacobson BA et al. Enhanced interleukin (IL)-13 responses in mice lacking IL-13 receptor alpha 2. J Exp Med 2003 197 : 703 9.
23. Mentink-Kane MM, Cheever AW, Thompson RW et al. IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci USA 2004 101 : 586 90.
24. Daines MO, Chen W, Tabata Y et al. Allergen-dependent solubilization of IL-13 receptor alpha2 reveals a novel mechanism to regulate allergy. J Allergy Clin Immunol 2007 119 : 375 83.
25. Thomassen MJ, Buhrow LT, Connors MJ, Kaneko FT, Erzurum SC, Kavuru MS. Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol 1997 17 : 279 83.
26. Kavuru MS, Dweik RA, Thomassen MJ. Role of bronchoscopy in asthma research. Clin Chest Med 1999 20 : 153 89.
27. Follettie MT, Ellis DK, Donaldson DD et al. Gene expression analysis in a murine model of allergic asthma reveals overlapping disease and therapy dependent pathways in the lung. Pharmacogenom J 2006 6 : 141 52.
28. Feng N, Lugli SM, Schnyder B et al. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2. Lab Invest 1998 78 : 591 602.
29. Zheng T, Zhu Z, Liu W et al. Cytokine regulation of IL-13Ralpha2 and IL-13Ralpha1 in vivo and in vitro. J Allergy Clin Immunol 2003 111 : 720 8.
30. David M, Ford D, Bertoglio J, Maizel AL, Pierre J. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways. Oncogene 2001 20 : 6660 8.
31. David M, Bertoglio J, Pierre J. TNF-alpha potentiates IL-4/IL-13-induced IL-13Ralpha2 expression. Ann N Y Acad Sci 2002 973 : 207 9.
32. Daines MO, Tabata Y, Walker BA et al. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling. J Immunol 2006 176 : 7495 501.
33. Andrews AL, Bucchieri F, Arima K et al. Effect of IL-13 receptor alpha2 levels on the biological activity of IL-13 variant R110Q. J Allergy Clin Immunol 2007.
34. Kellner J, Gamarra F, Welsch U, Jorres RA, Huber RM, Bergner A. IL-13Ralpha2 reverses the effects of IL-13 and IL-4 on bronchial reactivity and acetylcholine-induced Ca+ signaling. Int Arch Allergy Immunol 2007 142 : 199 210.
35. Plante S, Semlali A, Joubert P et al. Mast cells regulate procollagen I (alpha 1) production by bronchial fibroblasts derived from subjects with asthma through IL-4/IL-4 delta 2 ratio. J Allergy Clin Immunol 2006 117 : 1321 7.
36. Rahaman SO, Sharma P, Harbor PC, Aman MJ, Vogelbaum MA, Haque SJ. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells. Cancer Res 2002 62 : 1103 9.
37. Donaldson DD, Whitters MJ, Fitz LJ et al. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 1998 161 : 2317 24.
38. Caput D, Laurent P, Kaghad M et al. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 1996 271 : 16921 6.
39. Kawakami K, Taguchi J, Murata T, Puri RK. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway. Blood 2001 97 : 2673 9.
40. Kawakami K, Takeshita F, Puri RK. Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain. J Biol Chem 2001 276 : 25114 20.
41. Daines MO, Hershey GK. A novel mechanism by which interferon-gamma can regulate interleukin (IL)-13 responses. Evidence for intracellular stores of IL-13 receptor alpha -2 and their rapid mobilization by interferon-gamma. J Biol Chem 2002 277 : 10387 93.
42. David MD, Bertoglio J, Pierre J. Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression. Oncogene 2003 22 : 3386 94.